Good News, Men!
BEIJING, June 28 (Xinhuanet)-- Pfizer Inc., the world's largest drug maker, said on Monday that a review of its popular impotence treatment Viagra turned up no evidence of increased risk of blindness among patients taking the erectile dysfunction (ED) drug.
"After more than 10 years of rigorous clinical study and worldwide safety monitoring of a medicine used by more than 27 million men, there is no evidence to suggest a link between Viagra and blindness or other serious ocular events," said Joseph Feczko, Pfizer's chief medical officer, adding "several studies specifically looking into the effect of Viagra in the eye by Pfizer as well as independent ophthalmologic experts found Viagra to have no serious adverse effects on the eye."